Loading...
Back
BRNS
BWY
BRAINSWAY LTD
(BWAY)
2025 6-K
Follow
Summary
Share
Summary
Policy Announcement
7 Jan '26
Deep TMS Expansion
22 Dec '25
Clinical Trial Launch
17 Nov '25
FDA Clearance Received
13 Nov '25
Filing Report
12 Nov '25
Financial Results Report
12 Nov '25
NIH Grant Award
4 Nov '25
Filing Report
27 Oct '25
Warrant Exercise
14 Oct '25
Q2 Earnings Report
30 Sep '25
Filing Update
16 Sep '25
Shareholder Meeting Results
11 Sep '25
Filing Report
21 Aug '25
Filing Notice
20 Aug '25
Filing Report
13 Aug '25
Filing Update
13 Aug '25
Filing Announcement
6 Aug '25
Filing Update
11 Jun '25
Filing Notification
4 Jun '25
Filing Summary
13 May '25
Filing Notice
11 Mar '25
Positive Pilot Data
12 Dec '24
Feasibility Data Reported
20 Nov '24
Filing Update
12 Nov '24
Shareholder Meeting Results
5 Nov '24
Expansion in Asia
9 Oct '24
Meeting Notice
1 Oct '24
Private Placement Announcement
30 Sep '24
Expansion Announcement
16 Sep '24
PTSD Reimbursement Approved
10 Sep '24
New CMO Appointment
29 Aug '24
Brainsway Filing
6 Aug '24
Shareholder Meeting Results
17 Jun '24
Distribution Agreement
17 Jun '24
Clinical Trial Announcement
10 Jun '24
FDA Label Expansion
3 Jun '24
Filing Update
9 May '24
First Quarter Results
8 May '24
TMS Expansion Update
17 Apr '24
Parkinson's Treatment Review
4 Apr '24
Partnership Expansion
18 Mar '24
Financial Results Report
6 Mar '24
Clinical Evaluation Start
10 Jan '24
External Links:
SEC
Brainsway Ltd. filed a Form 6-K on September 16, 2025, providing updates related to their operations and registrations.
AI Assistant
Close
BRAINSWAY LTD
2025
6 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.